Author details

Full Name

Matthew J Gorman

Affiliation

ORCID

Career Start Year

2002

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36921600	Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccination.	Cell Rep Med	2023
38007686	Beta-spike-containing boosters induce robust and functional antibody responses to SARS-CoV-2 in macaques primed with distinct vaccines.	Cell Rep	2023
36907197	Predicting Vibrio cholerae infection and symptomatic disease: a systems serology study.	Lancet Microbe	2023
35073738	Serological Markers of SARS-CoV-2 Reinfection.	mBio	2022
35512013	Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates.	PLoS Biol	2022
35417540	Functional Compartmentalization of Antibodies in the Central Nervous System During Chronic HIV Infection.	J Infect Dis	2022
34812429	Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-Î± inhibitors.	Med	2021
33589636	Discrete SARS-CoV-2 antibody titers track with functional humoral stability.	Nat Commun	2021
34013263	Early cross-coronavirus reactive signatures of protective humoral immunity against COVID-19.	bioRxiv	2021
33796119	Non-neutralizing Antibodies May Contribute to Suppression of SIVmac239 Viremia in Indian Rhesus Macaques.	Front Immunol	2021
33688652	Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates.		2021
34006651	Influence of the Alternative Sigma Factor RpoN on Global Gene Expression and Carbon Catabolism in Enterococcus faecalis V583.	mBio	2021
33619473	Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-Mâ¿¢ vaccination.	Res Sq	2021
33564763	Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-Mâ¿¢ vaccination.	bioRxiv	2021
33873199	Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.	Nature	2021
34315825	Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates.	Science Translational Medicine	2021
33594366	Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates.	bioRxiv	2021
34652962	Early cross-coronavirus reactive signatures of humoral immunity against COVID-19.	Sci Immunol	2021
34485950	Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination.	Cell Rep Med	2021
32747832	Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics.	Nat Biomed Eng	2020
33200139	Epidemiological and immunological features of obesity and SARS-CoV-2.	medRxiv	2020
31204102	Fc Glycan-Mediated Regulation of Placental Antibody Transfer.	Cell	2019
31652847	In-Vitro Subtype-Specific Modulation of HIV-1 Trans-Activator of Transcription (Tat) on RNAi Silencing Suppressor Activity and Cell Death.	Viruses	2019
29590614	Oral Antibiotic Treatment of Mice Exacerbates the Disease Severity of Multiple Flavivirus Infections.	Cell Rep	2018
30120121	Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement.	Sci Immunol	2018
30573745	Efficacy of a T Cell-Biased Adenovirus Vector as a Zika Virus Vaccine.	Sci Rep	2018
29746837	An Immunocompetent Mouse Model of Zika Virus Infection.	Cell Host Microbe	2018
28081442	Mapping and Role of the CD8<sup>+</sup> T Cell Response During Primary Zika Virus Infection in Mice.	Cell Host Microbe	2017
28916645	Correction: Zika virus has oncolytic activity against glioblastoma stem cells.	J Exp Med	2017
28874392	Zika virus has oncolytic activity against glioblastoma stem cells.	J Exp Med	2017
29129917	Dengue virus-reactive CD8<sup>+</sup> T cells mediate cross-protection against subsequent Zika virus challenge.	Nat Commun	2017
27798603	Zika virus infection damages the testes in mice.	Nature	2016
27440901	The Interferon-Stimulated Gene IFITM3 Restricts Infection and Pathogenesis of Arthritogenic and Encephalitic Alphaviruses.	J Virol	2016
27384652	The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis.	J Virol	2016
27383988	A CRISPR screen defines a signal peptide processing pathway required by flaviviruses.	Nature	2016
27475895	Structural Basis of Zika Virus-Specific Antibody Protection.	Cell	2016
26468541	Interferon-Regulatory Factor 5-Dependent Signaling Restricts Orthobunyavirus Dissemination to the Central Nervous System.	J Virol	2015
26523970	The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity.	Nat Med	2015
24743949	Deficient IFN signaling by myeloid cells leads to MAVS-dependent virus-induced sepsis.	PLoS Pathog	2014
23734216	Drosophila host model reveals new enterococcus faecalis quorum-sensing associated virulence factors.	PLoS One	2013
11990697	Differences in adhesion receptor expression between immature and older platelets and red blood cells of neonates and adults.	Journal of Pediatric Hematology/Oncology	2002